Deal · Completed
Hepion Pharmaceuticals, Inc. and Gls
First filed 9 Oct 2026, 1 filing.
The deal
- Buyer
- Hepion Pharmaceuticals, Inc.
- Target
- Gls
- Status
- Completed
- Region
- US
of Acquisition or Disposition of Assets. The disclosure set forth above under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.
Source: The filing (SEC Form 8-K)
With a free account
A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.